Birkenstock starts trading today in key test of IPO market Birkenstock starts trading today in key test of IPO market Birkenstock starts trading today in key test of IPO market

Birkenstock starts trading today in key test of IPO market

Equities 5 minutes to read
PG
Peter Garnry

Head of Equity Strategy

Summary:  Birkenstock starts trading today on NYSE under the Saxo ticker symbol BIRK:xnys with its shares priced yesterday at the midpoint of the pricing range valuing the company at UDS 8.6bn. Birkenstock is expected to deliver revenue growth of 21% in FY23 (ending 30 September 2023) and a strong adjusted EBITDA margin above 35% reflecting the strong brand and premium pricing. Some key risks to consider are the equity valuation, concentrated revenue profile with 75% of revenue coming from just five core products, and then a bit low return on invested capital.


Key points in this equity note:

  • Birkenstock IPO was priced yesterday at the midpoint of the price range valuing the company at $8.6bn. The stock starts trading today with the Saxo ticker symbol BIRK:xnys

  • Birkenstock has a strong brand and has showed resilient growth during the pandemic with revenue growth expected at 21% in FY23 (ending 30 September 2023)

  • Some key risks about the Birkenstock business are a higher than average equity valuation, high revenue concentration in just five core products, and a bit low return on invested capital

A strong brand with attractive growth profile and profitability

Birkenstock is an iconic German-based sandal and shoe company and the next company to IPO this year following recent IPOs from Arm and Instacart. The stock was priced yesterday at $46 per share which was around the midpoint of the pricing range valuing the company at $8.6bn and raising $1.5bn. Birkenstock starts trading today on NYSE under the Saxo ticker symbol BIRK:xnys.

Investor appetite for Birkenstock has been solid and the LVMH Chairman Bernard Arnault’s family holding company has already invested in Birkenstock and has indicated that it is willing to increase its investment in Birkenstock. This is seen by many investors as a good sign for the outlook of the Birkenstock brand as LVMH is the leading luxury conglomerate in the world. The strength of the Birkenstock brand is also evident in the prospectus material. Birkenstock has strong US brand awareness and a high willingness to repurchase with each US customer owning more than three pairs of Birkenstock sandals or shoes.

Source: Birkenstock prospectus

The company has also successfully expanded its direct-to-consumer business to 38% which has been a key driver of the recent EBITDA margin expansion from 27% in FY20 (ending 30 September 2020) to expected 35.5% in FY23 (ending 30 September 2023). Revenue in FY23 is expected to be around $1.5bn up 21% y/y but revenue growth is likely to decrease further as global consumer spending is normalising post the pandemic.

In addition, the future growth of the company lies outside North America and Europe which today are 90% of revenue. Another underlying positive factor for the outlook is that revenue is almost equally balanced across all age groups suggesting that Birkenstock’s brand appeals to young people and thus future can be relied on. In addition, the customer base is predominantly high income groups and thus the company is able to sell its sandals and shoes at premium prices improving the profitability of the business.

There are also a few negative things to highlight about the business. With around $4bn in deployed capital in the business the return on invested capital could be better at just around 8% for the FY23. However, as the company becomes a publicly listed company this is likely to be a key priority going forward. Birkenstock also has a high product concentration with 75% of revenue coming just five core products. In terms of equity valuation it is set such that Birkenstock is valued at a premium to say Adidas. Birkenstock is valued at a FY24 EV/EBITDA multiple of around 18x compared to Adidas at around 15.3x, but Birkenstock also has a higher growth profile due to low revenue in Asia and more potential for direct-to-consumer penetration.

Post IPO performance of Arm, Klaviyo, and Instacart

Birkenstock is the fourth important IPO this year as the IPO market is coming back as investors are now more willing to invest in IPOs given the outlook this year has changed from certainty of recession to growth being robust. Of the three recent IPOs from Arm, Klaviyo and Instacart two of them have seen gains since the IPO. It is only Instacart that is down since the IPO.

Source: Bloomberg
Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.